The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Aug. 25, 2020
Filed:
Sep. 12, 2019
Applicant:
Axerovision, Inc., Carlsbad, CA (US);
Inventor:
Achim H. Krauss, San Marcos, CA (US);
Assignee:
AxeroVision, Inc., Carlsbad, CA (US);
Attorney:
Primary Examiner:
Assistant Examiner:
Int. Cl.
CPC ...
A61K 31/445 (2006.01); A61P 27/04 (2006.01); A61K 9/00 (2006.01); A61K 9/06 (2006.01); A61K 9/08 (2006.01); A61K 45/06 (2006.01); A61K 31/192 (2006.01); A61K 31/196 (2006.01); A61K 31/573 (2006.01); A61K 38/13 (2006.01);
U.S. Cl.
CPC ...
A61K 31/445 (2013.01); A61K 9/0048 (2013.01); A61K 9/06 (2013.01); A61K 9/08 (2013.01); A61K 45/06 (2013.01); A61P 27/04 (2018.01); A61K 31/192 (2013.01); A61K 31/196 (2013.01); A61K 31/573 (2013.01); A61K 38/13 (2013.01); A61K 2300/00 (2013.01);
Abstract
The invention relates to antagonists of integrin α4 and their use in pharmaceutical compositions, primarily topically administered ophthalmic compositions. The pharmaceutical compositions are useful for treating ocular inflammatory conditions, such as dry eye disease, non-infectious uveitis (e.g., anterior, intermediate, posterior, pan-uveitis), non-infectious conjunctivitis, iritis, or scleritis in animals, and particularly mammals, including humans.